Sales & Marketing Sponsored 5 forces reshaping pharma commercialisation in 2026 As infrastructure bottlenecks ease and regulatory frameworks mature, pharma's AI adoption is shifting from proof-of-concept to production-grade deployment
Digital Sponsored Axtria Ignite 2025: A VIP roundtable on agentic AI At Axtria Ignite 2025, over 20 pharma senior executives stepped into a VIP roundtable to discuss how best to unlock agentic AI’s tranformative value.
Digital Agentic AI, culture shifts, and commercialisation today: Ant... Hear Anthony Cilento, VP, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI.
Digital Partner Content Axtria and Kedaara Capital Announce Strategic $240 Million I... The transaction delivers total liquidity of $240 million, making it one of the largest employee-centric liquidity events in the industry.
Digital Axtria Ignite 2025: Ritesh Mehra talks AI, culture, and comm... At Axtria Ignite 2025, web editor Nicole Raleigh spoke with Ritesh Mehra, CFO, US, at Ferring Pharmaceuticals.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.